CORCEPT THERAPEUTICS INC Operating Income Loss

• CORCEPT THERAPEUTICS INC showed a decrease of -67.3% in Operating Income Loss from 2024 to 2025.
• This data is from CORCEPT THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), CORCEPT THERAPEUTICS INC's Operating Income Loss has grown by 321.2%.
• Historical annual values: Fiscal year 2025: $44.80 million | Fiscal year 2024: $136.95 million | Fiscal year 2023: $107.28 million | Fiscal year 2022: $112.63 million | Fiscal year 2021: $124.48 million | Fiscal year 2020: $128.20 million | Fiscal year 2019: $111.61 million | Fiscal year 2018: $89.50 million | Fiscal year 2017: $52.86 million | Fiscal year 2016: $10.18 million | Fiscal year 2015: -$3.44 million | Fiscal year 2014: -$27.62 million | Fiscal year 2013: -$41.50 million | Fiscal year 2012: -$36.27 million | Fiscal year 2011: -$32.33 million | Fiscal year 2010: -$27.44 million | Fiscal year 2009: -$20.25 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026